Tvardi Therapeutics, Inc. Common Stock Share Price
NASDAQ: TVRDHealthcare
Live Tvardi Therapeutics, Inc. Common Stock Share Price Chart
O H L
Tvardi Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$1.60Low
$1.62High
Markets Today
| Previous Close | $1.62 |
|---|---|
| Open | $1.62 |
| Volume | 28,029 |
| Day's Range | $1.60 - $1.62 |
| 52W Range | $1.50 - $43.65 |
| Market Cap | $23.08 M |
Historical Performance
| 1M Returns | -6.99 |
|---|---|
| 3M Returns | -32.95 |
| 6M Returns | -52.47 |
| 1Y Returns | -95.57 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Tvardi Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $23.08 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | $-2.78 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.94 |
| EBITDA | $-26.65 M |
| Profit Margin | N/A |
| Market Cap | $23.08 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | $-2.78 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.94 |
| EBITDA | $-26.65 M |
| Profit Margin | N/A |
Tvardi Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$8.87 M | -$5.94 M | -$7.59 M | -$7.05 M | -$6.63 M |
| EBITDA | -$8.85 M | -$5.91 M | -$7.56 M | -$7.03 M | -$6.61 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $23.00 K | $24.00 K | $24.00 K | $24.00 K | $23.00 K |
| Income Before Tax | $4.17 M | -$5.53 M | -$7.28 M | -$6.80 M | -$6.46 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income + | $4.17 M | -$5.53 M | -$7.28 M | -$6.80 M | -$6.46 M |
| Net Profit Margin | - | - | - | - | - |
Tvardi Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Share Capital | $9.00 K | $9.00 K | $9.00 K | $9.00 K | $9.00 K |
| Reserve & Surplus | -$97.66 M | -$103.17 M | -$110.44 M | -$117.25 M | -$123.71 M |
| Non-Current Liabilities | $145.00 K | $115.00 K | $85.00 K | $54.00 K | $22.00 K |
| Current Liabilities | $10.68 M | $11.04 M | $11.04 M | $11.26 M | $9.11 M |
| Total Liabilities | $10.82 M | $11.15 M | $11.13 M | $11.31 M | $9.13 M |
| Fixed Assets | $422.00 K | $398.00 K | $374.00 K | $350.00 K | $327.00 K |
| Current Assets | $43.13 M | $38.44 M | $31.54 M | $25.33 M | $17.07 M |
| Total Assets | $43.75 M | $39.02 M | $32.07 M | $25.82 M | $17.52 M |
Tvardi Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Net Income | $4.17 M | -$5.53 M | -$7.28 M | -$6.80 M | -$6.46 M |
| Operating Cash Flow | -$5.87 M | -$4.26 M | -$5.68 M | -$5.86 M | -$9.23 M |
| Investing Cash Flow | -$9.55 M | $5.35 M | $5.00 M | $4.98 M | $5.14 M |
| Financing Cash Flow | $24.63 M | -$322.00 K | $1.00 K | $0 | $0 |
| Change in Cash | $9.21 M | $770.00 K | -$684.00 K | -$883.00 K | -$4.09 M |
Tvardi Therapeutics, Inc. Common Stock Return Calculator
The Tvardi Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Tvardi Therapeutics, Inc. Common Stock
Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.
Popular Stocks
FAQs
What is the share price of Tvardi Therapeutics, Inc. Common Stock today?
Tvardi Therapeutics, Inc. Common Stock (TVRD) share price as of September 18, 2026 is $1.58. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Tvardi Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Tvardi Therapeutics, Inc. Common Stock (TVRD) Share by opening an international trading account with Angel One.
How can I purchase Tvardi Therapeutics, Inc. Common Stock shares in India?
Purchasing Tvardi Therapeutics, Inc. Common Stock (TVRD) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Tvardi Therapeutics, Inc. Common Stock (TVRD) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Tvardi Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Tvardi Therapeutics, Inc. Common Stock (TVRD) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Tvardi Therapeutics, Inc. Common Stock?
The market capitalization of Tvardi Therapeutics, Inc. Common Stock on September 18, 2026, is $23.08 M.
In which sector Tvardi Therapeutics, Inc. Common Stock belongs?
Tvardi Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Tvardi Therapeutics, Inc. Common Stock stocks?
In order to invest in Tvardi Therapeutics, Inc. Common Stock (TVRD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
